Back to Search
JOEL STREHL, D.O.
D.O.
Surgery Physician
NPI: 1780971614IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgery PhysicianPrimary
Surgery
Code: 208600000X
5101019578(MI)
CMS Specialties
PrimaryGENERAL SURGERY
Education
LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE, ERIE
Class of 2011
Research & Publications (20)
Increase of in vivo antitumoral activity by CD40L (CD154) gene transfer into pancreatic tumor cell-dendritic cell hybrids.
PMID 19546834·Pancreas·2009
7-preclinical
Long-term survival of a patient with small cell lung cancer after nine lines of chemotherapy and radiation.
PMID 18787355·Onkologie·2008
5-case
Pegfilgrastim as hematopoietic support for dose-dense chemoimmunotherapy with R-CHOP-14 as first-line therapy in elderly patients with diffuse large B cell lymphoma.
PMID 17235504·Support Care Cancer·2007
3-trial
High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma.
PMID 19675710·Ger Med Sci·2007
8-other
Cytokine-induced killer cells are type II natural killer T cells.
PMID 19675715·Ger Med Sci·2007
8-other
Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.
PMID 16617302·Gene Ther·2006
7-preclinical
Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients.
PMID 16504141·BMC Infect Dis·2006
1-meta
Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia.
PMID 16179374·Blood·2006
8-other
Cholecystitis in neutropenic patients: retrospective study and systematic review.
PMID 16483649·Leuk Res·2006
1-meta
DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis.
PMID 17169800·Leuk Lymphoma·2006
3-trial
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
PMID 16982464·Cancer Invest·2006
3-trial
Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo.
PMID 16772371·Int Immunol·2006
7-preclinical
Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.
PMID 16734623·Clin Exp Immunol·2006
8-other
Neutropenic enterocolitis in adults: systematic analysis of evidence quality.
PMID 15946304·Eur J Haematol·2005
1-meta
Transfection of human monocyte-derived dendritic cells with CpG oligonucleotides.
PMID 15877606·Immunol Cell Biol·2005
8-other
Retroviral IFN-alpha gene transfer combined with gemcitabine acts synergistically via cell cycle alteration in human pancreatic carcinoma cells implanted orthotopically in nude mice.
PMID 15320962·J Interferon Cytokine Res·2004
7-preclinical
High-dose chemotherapy followed by autologous stem cell transplantation as first-line therapy in aggressive non-Hodgkin's lymphoma: a meta-analysis.
PMID 14607760·Haematologica·2003
1-meta
Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine.
PMID 14562009·Br J Cancer·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 701 W Front St Ste 200
Traverse City, MI 49684 - Phone
- (231) 346-4000
Quick Facts
- NPI
- 1780971614
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile